AT2 receptor stimulation enhances antihypertensive effect of AT1 receptor antagonist in hypertensive rats

Hypertension

Volumn 34, Issue 5, 1999, Pages 1112-1116

  Barber, Melissa N ^a   Sampey, Donella B ^a   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; Hypertension, arterial; Rats; Receptors, angiotensin; Vasodilation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN ANTAGONIST; CANDESARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DEPRESSOR RESPONSE; HEART RATE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION;

EID: 0032733920     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1112     Document Type: Article

References (32)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology. Diagnosis and Management. New York, NY: Raven Press Ltd; 1995:1763-1796.
2. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Ann Rev Pharmacol Toxicol 1996;36: 281-306.
3. Johnston CI. Angiotensin receptor antagonists: focus on losartan. Lancet 1995;346:1403-1407.
4. Viswanathan M, Tsutsumi K, Correa FMA, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun. 1991;179:1361-1367.
5. 2, receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
6. De Gasparo M, Levens N. Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme? Pharmacol Toxicol. 1998;82:257-271.
7. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1191.
8. Stoll M, Meffert S, Stroth U, Unger T. Growth or antigrowth: angiotensin and the endothelium. J Hypertens. 1995;13:1529-1534.
9. 2 receptors. Br J Pharmacol 1998;125:1429-1436.
10. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type 2 receptor gene in mice. Nature. 1995;377:744-747.
11. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
12. Campbell DJ. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists. Clin Exp Pharmacol Physiol 1996;(suppl 3):S125-S131.
13. Scheuer DA, Perone MH, Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol 1993; 264:R917-R923.
14. Munzenmaier D, Greene A. Opposing actions of angiotemin II on microvascular growth and arterial blood pressure. Hypertension 1996;27-760-765.
15. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
16. Whitebread S, Mele M, Kamber B, De Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989;163:284-291.
17. 2 receptor in PC12W cells. Regul Pept. 1993;44:207-213.
18. 2) receptor in R3T3 cells. Biochem Biophys Res Commun. 1996; 228:825-830.
19. Lo M, Liu K, Lantelme P, Sassard J. Subtype 2 angiotensin receptors controls pressure-natriuresis in rats. J Clin Invest. 1995;95:1394-1397.
20. 2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol. 1993;249:85-93.
21. 2 receptor ligands CGP 42112B and PD 123319 after blockade of the renin-angiotensin system. Eur J Pharmacol. 1994;259:27-36.
22. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (candesartan), and its prodrug. (±)-1-cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylate (TCV-116). J Pharmacol Exp Ther. 1993;266:114-120.
23. 1 receptor antagonist CV-11974 in conscious renal hypertensive rats Hypertension 1995;26:989-997.
24. Li XC, Widdop RE. Angiotensin type 1 receptor antagonists candesartan and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats. Clin Sci. 1996;91:147-154.
25. Gigante B, Piras O, De Paolis P, Porcellini A, Natale A, Volpe M. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effects of losartan in salt-restricted rats. J Hypenens. 1998;16-2039-2043.
26. Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T, Nishikawa K. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (±)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylate (TCV-116). in various hypertensive rats. J Pharmacol Exp Ther. 1994; 268:1540-1547.
27. 1-receptor antagonist. EXP 3174. Br J Pharmacol. 1992;107:873-880.
28. Liu Y, Yang X, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 2 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;99:1926-1935.
29. Nora EH, Munzenmaier DH, Hansen-Smith FM, Lombard JH, Greene AS. Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol. 1998;275:H1395-H1403.
30. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension. 1998;32: 467-472.
31. 1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest. 1996;97:1978-1982.
32. 2) receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100: 264-269.